Therapeutic options for severe pulmonary hypertension

Clinics in Chest Medicine

Volumn 18, Issue 3, 1997, Pages 595-609

  Palevsky, H I ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; VASODILATOR AGENT;

ANTICOAGULANT THERAPY; HUMAN; MEDICAL DECISION MAKING; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; TREATMENT OUTCOME; VASODILATATION;

EID: 0030772090     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70404-4     Document Type: Article

References (129)

1. 2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease Circulation 88 1993 2117
2. W.R. Anger P.F. Fedullo K.M. Moser Chronic major-vessel thromboembolic pulmonary artery obstruction: Appearance at angiography Radiology 182 1992 393
3. K. Bando J.M. Armitage I.L. Paradis Indications for and results of single, bilateral and heart-lung transplantation for pulmonary hypertension J Thorac Cardiovasc Surg 108 1994 1056
4. K. Bando R.J. Keenan I.L. Paradis Impact of pulmonary hypertension on outcome after single-lung transplantation Ann Thorac Surg 58 1994 1336
5. R.J. Barst J.C. Hall S.A. Stalcup Response to prostacyclin predicts response to subsequent vasodilator therapy in children and young adults with primary pulmonary hypertension E.F. Doyle M.A. Engle Cardiology 1986 Springer-Verlag New York 952
6. R.J. Barst L.J. Rubin W.A. Long A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296
7. R.J. Barst L.J. Rubin M.D. McGoon Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin Ann Intern Med 121 1994 409
8. J.J. Belch H.A. Capell E.D. Cooke Oral iloprost as a treatment for Reynaud's syndrome: A double-blind multicenter placebo-controlled study Ann Rheum Dis 52 1995 197
9. R.O. Bonow N. Galie M. Gheorghiade Prostacyclin: Basic principles and clinical application in congestive heart failure and primary pulmonary hypertension Am J Cardiol 75 1995 1A
10. R.N. Channick J.W. Newhart F.W. Johnson Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: An ambulatory delivery system and initial clinical tests Chest 109 1996 1545
11. A. Chaouat E. Weitzenblum R. Higenbottom The role of thrombosis in severe pulmonary hypertension Eur Respir J 9 1996 356
12. B.W. Christman C.D. McPherson J.H. Newman An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension N Engl J Med 327 1992 70
13. A.L. Coates K. Desmond M.I. Asher The effect of digoxin on exercise capacity and exercising cardiac function in cystic fibrosis Chest 82 1982 543
14. M. Cohen V. Fuster W.D. Williams Anticoagulation in the treatment of pulmonary hypertension A.P. Fishman The Pulmonary Circulation: Normal and Abnormal Mechanisms, Management, and the National Registry 1990 University of Pennsylvania Press Philadelphia 501
15. I. Coma-Canella J. Lopez-Sendon Hemodynamic effects of nifedipine, nitroglycerin and prazosin in pulmonary hypertension following ingestion of toxic oil Eur Heart J 4 1983 566
16. C.B. Cooper J. Waterhouse P. Howard Twelve-year clinical study of patients with hypoxic cor pulmonale given long-term domiciliary oxygen therapy Thorax 42 1987 105
17. D.R. Dantzker G.E. D'Alonzo L. Gianotti Vasodilators and primary pulmonary hypertension: Variability of long-term response Chest 95 1989 1185
18. U.K. Das Prostaglandins and pulmonary hypertension—further evidence Med Hypotheses 7 1981 621
19. J.-P. Derenne B. Fluery R. Pariente Acute respiratory failure of chronic obstructive lung disease Am Rev Respir Dis 138 1988 1006
20. A.T. Dinh-Xuan T.W. Higenbottam C.A. Clelland Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease N Engl J Med 324 1991 1539
21. A.T. Dinh-Xuan T.W. Higenbottam J.P. Scott Effects of long-term treatment with iloprost, a prostacyclin analogue, on exercise tolerance in patients with primary pulmonary hypertension Am Rev Respir Dis 141 1990 889
22. G.J. Dusting S. Moncada J.R. Vane Prostaglandins, their intermediates and precursors: Cardiovascular actions and regulatory roles in normal and abnormal circulatory systems Prog Cardiovasc Dis 6 1979 405
23. P.R. Eisenberg C. Lucore L. Kaufman Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension Circulation 82 1990 841
24. T.W. Evans D.G. McCormack J.M. Morgan Adenosine as a vasodilator in primary pulmonary hypertension Am Rev Respir Dis 141 1990 665
25. S.B. Eysmann H.I. Palevsky N. Reichek Echo/Doppler and hemodynamic correlates of vasodilator responsiveness in primary pulmonary hypertension Chest 99 1991 1066
26. P.F. Fedullo W.E. Anger R.N. Channick Chronic thromboembolic pulmonary hypertension Clin Chest Med 16 1995 353
27. G.T. Ferguson R.M. Cherniack Management of chronic obstructive pulmonary disease N Engl J Med 328 1993 1017
28. Nitric oxide M.P. Fink New Horizons 3 1995 1
29. A.P. Fishman Chronic cor pulmonale Am Rev Respir Dis 114 1976 775
30. A.P. Fishman Pulmonary circulation A.P. Fishman Handbook of Physiology, section 3; The Respiratory System, vol I; Circulation and Nonrespiratory Functions 1985 American Physiological Society Bethesda, MD 93
31. A.P. Fishman G.G. Pietra Primary pulmonary hypertension Ann Rev Med 31 1980 421
32. D.C. Flenley Long-term home oxygen therapy Chest 87 1985 99
33. D.S. Fuleihan S. Mookherjee J. Potts Sodium nitroprusside: A new role as a pulmonary vasodilator Am J Cardiol 43 1979 405
34. V. Fuster P.M. Steele W.D. Edwards Primary pulmonary hypertension: Natural history and the importance of thrombosis Circulation 70 1984 580
35. W.B. Gefter H. Hatabu K.B. Gyupta Pulmonary thromboembolism: Recent developments in diagnosis using computed tomography and magnetic resonance imaging. State-of-the-Art Radiology 197 1995 561
36. A.R. Glanville C.M. Burke J. Theodore Primary pulmonary hypertension. Length of survival in patients referred for heart–lung transplantation Chest 91 1987 675
37. B.P. Griffith R.L. Hardesty J.M. Armitage A decade of lung transplantation Ann Surg 218 1993 310
38. P.D. Henry Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem Am J Cardiol 46 1980 1047
39. J.B. Hermiller D. Bambach M.J. Thompson Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension Ann Intern Med 97 1982 480
40. D. Hess R. Kacmarek H. Imanaka Administration of inhaled nitric oxide by nasal cannula American Journal of Respiratory and Critical Care Medicine 151 1995 44
41. T. Higenbottam Inhaled nitric oxide: A magic bullet? Q J Med 86 1993 555
42. T.W. Higenbottam D. Spiegelhalter J.P. Scott Prostacyclin (epoprostenol) and heart–lung transplantation as treatments for severe pulmonary hypertension Br Heart J 70 1993 366
43. J. Hirsh Heparin N Engl J Med 324 1991 1565
44. J.D. Hughes L.J. Rubin Primary pulmonary hypertension: An analysis of 28 cases and a review of the literature Medicine 65 1986 56
45. A.L. Hyman Pulmonary vaso-constriction due to non-occlusive distension of large pulmonary arteries in the dog Circ Res 23 1968 401
46. L.J. Ignarro G.M. Buga K.S. Wood EDRF produced and released from artery and vein is nitric oxide Proc Natl Acad Sci U S A 84 1987 9265
47. S. Inbar B.J. Schrader E. Kaufmann Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension J Am Coll Cardiol 21 1993 413
48. S.W. Jamieson W.R. Anger P.F. Fedullo Experience and results with 150 pulmonary thromboendarterectomy operations over a 29 month period J Thoracic Cardiovasc Surg 106 1993 116
49. M.A. Kelley R.A. Panettieri Jr A.V. Krupinski Resting single-breath diffusing capacity as a screening test for exercise-induced hypoxemia Am J Med 80 1986 807
50. D. Kerstein P.S. Levy D.T. Hsu Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension Circulation 91 1995 2028
51. J.P. Kinsella S.R. Neish E. Shaffer Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn Lancet 340 1992 819
52. V.R. Kshellry T.J. Kroshus K. Savik Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients Chest 110 1996 704
53. C.V. Leier D. Bambach S. Nelson Captopril in primary pulmonary hypertension Circulation 67 1983 155
54. S.M. Levine S.G. Kenkinson C.L. Bryan Ventilation–perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension Chest 101 1992 401
55. W. Long R. Barst A.P. Fishman Acute hemodynamic effects of prostacyclin in 65 primary pulmonary hypertension patients J Crit Care 1 1986 127
56. 1 treatment of pulmonary hypertension Am Rev Respir Dis 136 1987 773
57. E. Lupi-Herrera D. Bialostozky A. Sobrino The role of isoproterenol in pulmonary artery hypertension of unknown etiology (primary) Chest 79 1981 292
58. E. Lupi-Herrera J. Sandoval M. Seoane The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause Circulation 65 1982 645
59. P.N. Mathur R.C.P. Powles S.O. Pugsley Effects of digoxin on right ventricular function in severe chronic airflow obstruction Ann Intern Med 92 1981 283
60. D.G. McCormack B. Clarke P.J. Carnes Characterization of adenosine receptors in human pulmonary arteries Am J Physiol 256 1989 41
61. M.D. McGoon R.E. Vliestra Vasodilator therapy for primary pulmonary hypertension Mayo Clin Proc 59 1984 672
62. R.C. McGrath J.V. Weil Adverse effects of normovolemic polycythemia and hypoxia on hemodynamics in the dog Circ Res 43 1978 793
63. A.A. McLeod D.E. Jewitt Drug treatment of primary pulmonary hypertension Drugs 31 1986 177
64. K.M. Moser C.M. Bloor Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension Chest 103 1993 685
65. K.M. Moser P.O. Daily K. Peterson Thromboendarterectomy for chronic, major vessel thromboembolic pulmonary hypertension: Immediate and long-term results in 42 patients Ann Intern Med 107 1987 560
66. P. Nicod K. Peterson M. Levine Pulmonary angiography in severe, chronic pulmonary hypertension Ann Intern Med 107 1987 565
67. M.R. Nihill M.P. O'Laughlin C.E. Mulline Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease Cathet Cardiovasc Diagn 24 1991 166
68. M. Nootens B. Schrader E. Kaufmann Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension Chest 107 1995 54
69. G.R. Owens R.M. Rogers B.E. Pennock The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease N Engl J Med 310 1984 1218
70. M. Packer Vasodilator therapy for primary pulmonary hypertension: Limitations and hazards Ann Intern Med 103 1985 258
71. M. Packer B. Greenberg B. Masore Deleterious effects of hydralazine in patients with pulmonary hypertension N Engl J Med 306 1982 1326
72. H.I. Palevsky Exercise and the pulmonary circulation A. Leff Cardiopulmonary Exercise Testing 1986 Grune & Stratton Orlando, FL 89
73. H.I. Palevsky L.H. Edmunds Jr Pulmonary thromboembolism L.H. Edmunds Cardiac Surgery in the Adult 1997 McGraw-Hill New York 1319 1344
74. H.I. Palevsky A.P. Fishman Chronic cor pulmonale J Am Med Assoc 263 1990 2347
75. H.I. Palevsky W. Long J. Crow Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension Circulation 82 1990 2018
76. H. Palevsky G.G. Pietra A.P. Fishman Pulmonary veno-occlusive disease and its response to vasodilator agents Am Rev Respir Dis 142 1990 426
77. H.I. Palevsky B.L. Schloo G.G. Pietra Primary pulmonary hypertension: Vascular structure, morphometry and responsiveness to vasodilator agents Circulation 80 1989 1207
78. R.M.J. Palmer A.G. Ferrige S. Moncada Nitric oxide release accounts for the biological activity of EDRF Nature 327 1987 524
79. M.K. Pasque E.P. Toulock J.D. Cooper Single lung transplantation for pulmonary hypertension. Single institution experience in 34 patients Circulation 92 1995 2252
80. R.G. Pearl M.H. Rosenthal J.P.A. Ashton Pulmonary vasodilator effects of nitroglycerin and sodium nitroprusside in canine oleic acid induced pulmonary hypertension Anesthesiology 58 1983 514
81. R.G. Pearl M.H. Rosenthal J.S. Schroeder Acute hemodynamic effects of nitroglycerin in pulmonary hypertension Ann Intern Med 99 1983 9
82. J. Pepke-Zaba T.W. Higenbottam A.T. Dinh-Xuan Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension Lancet 338 1991 1173
83. B. Person R.J. Proctor Primary pulmonary hypertension: Response to indomethacin, terbutaline, and isoproterenol Chest 76 1979 601
84. R.H. Peter L. Rubin The pharmacologic control of the pulmonary circulation in pulmonary hypertension Adv Intern Med 29 1984 494
85. G.G. Pietra The histopathology of primary pulmonary hypertension A.P. Fishman The Pulmonary Circulation: Normal and Abnormal: Mechanisms, Management and the National Registry 1990 University of Pennsylvania Press Philadelphia 459
86. D.A. Pietro K.A. LaBresh R.M. Shulman Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol N Engl J Med 310 1984 1032
87. J.E. Powe H.I. Palevsky K.E. McCarthy Usefulness of lung scanning in the evaluation of patients with pulmonary arterial hypertension Radiology 164 1987 727
88. J.T. Reeves B.M. Groves D. Turkevich The case for treatment of selected patients with primary pulmonary hypertension Am Rev Respir Dis 134 1986 342
89. M. Reidel V. Stanke J. Widimsky Long-term follow-up of patients with pulmonary thromboembolism: Late prognosis and evaluation of hemodynamic and respiratory data Chest 81 1982 151
90. S. Rich The role of thrombosis in pulmonary hypertension Chest 103 1993 660
91. S. Rich B.H. Brundage High-dose calcium channel blocking therapy for primary pulmonary hypertension: Evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy Circulation 76 1987 134
92. S. Rich B.H. Brundage Pulmonary hypertension: A cellular basis for understanding the pathophysiology and treatment J Am Coll Cardiol 14 1990 545
93. S. Rich D.R. Dantzker S.M. Ayres Primary pulmonary hypertension: A national prospective study Ann Intern Med 107 1987 216
94. S. Rich E. Kaufmann P.S. Levy The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 1992 76
95. S. Rich J. Martinez W. Lam Captopril as treatment for patients with pulmonary hypertension Br Heart J 48 1982 272
96. J.D. Roberts D.M. Polaner P. Lang Inhaled nitric oxide in persistent pulmonary hypertension of the newborn Lancet 340 1992 818
97. R. Rossaint K.J. Flake F. Lopez Inhaled nitric oxide for the adult respiratory distress syndrome N Engl J Med 328 1993 399
98. R. Rossaint U. Pison H. Gerlach Inhaled nitric oxide: Its effects on pulmonary circulation and airway smooth muscle cells Eur Heart J 14 suppl I 1993 133
99. A. Rozkovec P. Montanes C.M. Oakley Factors that influence the outcome of primary pulmonary hypertension Br Heart J 55 1986 449
100. L.J. Rubin Primary pulmonary hypertension N Engl J Med 336 1997 111
101. Rubin L.J. chairman Primary pulmonary hypertension: An ACCP consensus statement Chest 104 1993 236
102. L.J. Rubin R.H. Peter Oral hydralazine therapy for primary pulmonary hypertension N Engl J Med 302 1980 69
103. L.J. Rubin R.H. Peter Therapy of pulmonary heart disease L.J. Rubin Pulmonary Heart Disease 1984 Martinus Nijhoff Publishing Boston 325
104. L.J. Rubin B.M. Groves J.T. Reeves Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension Circulation 66 1982 334
105. L.J. Rubin J. Mendoza M. Hood Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol) Ann Intern Med 112 1990 485
106. J.N. Ruskin A.M. Hutter Primary pulmonary hypertension treated with oral phentolamine Ann Intern Med 90 1979 772
107. 2 analogue, beraprost, in primary and secondary pulmonary hypertension Am J Cardiol 78 1996 244
108. L.L. Schulman B.A. Grossman J. Owen Platelet activation and fibrinopeptide formation in pulmonary hypertension Chest 104 1993 1690
109. J.P. Scott T.W. Higenbottam J. Wallwork The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension Br J Clin Pharmacol 6 1990 231
110. D. Shure G. Gregoratos K.M. Moser Fiberoptic angioscopy: Role in the diagnosis of chronic pulmonary arterial obstruction Ann Intern Med 103 1985 844
111. O. Sitbon F. Brenot A. Denjean Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension: A dose-response study and comparison with prostacyclin American Journal of Respiratory and Critical Care Medicine 151 1995 384
112. G.I. Snell R.F. Salamonsen P. Bergin Inhaled nitric oxide used as a bridge to heart–lung transplantation in a patient with end-stage pulmonary hypertension American Journal of Respiratory and Critical Care Medicine 151 1995 1263
113. G.C. Sutton R.J. Hall I.H. Kerr Clinical course and late prognosis of subacute massive, acute minor and chronic pulmonary thromboembolism Br Heart J 39 1977 1135
114. R.M. Timms R.U. Khaja G.W. Williams The nocturnal oxygen therapy trial. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease Ann Intern Med 102 1985 29
115. M. Ubakata M. Motegi Y. Sendo Systemic lupus erythematous with pulmonary hypertension—normalization of pulmonary artery pressure by long-term administration of beraprost sodium Nippon Kyobu Shikkan Gakkai Zasshi 33 1995 1307
116. N.G. Uren P.F. Ludman T. Crake Response of the pulmonary circulation to acetylcholine, calcitonin gene-related peptide, substance P and oral nicardipine in patients with primary pulmonary hypertension J Am Coll Cardiol 19 1992 835
117. N.F. Voelkel E.K. Weir Etiologic mechanisms in primary pulmonary hypertension E.K. Weir J.T. Reeves Pulmonary Vascular Physiology and Pathophysiology 1989 Marcel Dekker New York 513
118. C.A. Wagenvoort N. Wagenvoort Pathology of Pulmonary Hypertension 1977 Wiley New York
119. D. Walmrath T. Schneider J. Pilch Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis American Journal of Respiratory and Critical Care Medicine 151 1995 724
120. S.A. Webb S. Stott P.V. van Heerden The use of inhaled aerosolized prostacyclin in the treatment of pulmonary hypertension secondary to pulmonary embolism Intensive Care Med 22 1996 353
121. E.K. Weir The United States experience with the acute and chronic treatment of primary pulmonary hypertension Eur Heart J 9 suppl J 1988 33
122. E.K. Weir Acute vasodilator testing and pharmacological treatment of primary pulmonary hypertension A.P. Fishman The Pulmonary Circulation: Normal and Abnormal: Mechanisms, Management and the National Registry 1990 University of Pennsylvania Press Philadelphia 485
123. E.K. Weir S.L. Archer J.E. Edwards Chronic primary and secondary thromboembolic pulmonary hypertension Chest 93 S 1988 149
124. E.K. Weir L.J. Rubin S.M. Ayres The acute administration of vasodilators in primary pulmonary hypertension: Experience from the National Institutes of Health registry on primary pulmonary hypertension Am Rev Respir Dis 140 1989 1623
125. P. Wood E.M. Besterman M.K. Towers The effect of acetylcholine on pulmonary vascular resistance and left atrial pressure in mitral stenosis Br Heart J 19 1957 279
126. P.A. Woodmansey L. O'Toole K.S. Channer Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension Heart 75 1996 171
127. T.E. Young L.J. Lundquist E. Chesler Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension Am J Cardiol 51 1983 195
128. W.M. Zapol S. Rimar N. Gillis Nitric oxide and the lung: An NHLBI workshop summary American Journal of Respiratory and Critical Care Medicine 149 1994 1375
129. B. Zwissler M. Welle K. Mermer Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction J Cardiothorac Vasc Anesth 9 1995 283